Skip to content
GenoLensGenoLens

CSGALNACT1

Chr 8p21.3

chondroitin sulfate N-acetylgalactosaminyltransferase 1

Aliases:
CSGalNAcT-1, FLJ11264, ChGn
MANE:
ENST00000692225.2

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Congenital disorders of glycosylation

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Skeletal dysplasia

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • skeletal dysplasia, mild, with joint laxity and advanced bone age

    0.77
  • congenital disorder of glycosylation

    0.46
  • Abnormality of the skeletal system

    0.45
  • Desbuquois syndrome

    0.39
  • alcohol drinking

    0.31
  • Vertigo

    0.28
  • placenta praevia

    0.28
  • metabolic syndrome

    0.28
  • venous thromboembolism

    0.28
  • hyperlipidemia

    0.27

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Chondroitin sulfate N-acetylgalactosaminyltransferase 1

Transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of glucuronic acid (GlcUA). Required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains. Important role in chondroitin chain biosynthesis in cartilage formation and subsequent endochondral ossification (PubMed:11788602, PubMed:12163485, PubMed:12446672, PubMed:17145758, PubMed:31705726). Moreover, is involved in the metabolism of aggrecan (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.